Our own studies suggest that serum from SIRS patients strongly suppresses apoptosis induced by the broad range PKC inhibitor STS in several myeloid and lymphoid cell lines including primary neutrophils [18]. The gene discussed is PRRT2; the disease is systemic inflammatory response syndrome.